Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to -$272000.0.

  • Bio's Other Working Capital Changes fell 36.9% to -$272000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11000.0, marking a year-over-year increase of 11341.46%. This contributed to the annual value of -$227000.0 for FY2024, which is 38024.69% down from last year.
  • Latest data reveals that Bio reported Other Working Capital Changes of -$272000.0 as of Q3 2025, which was down 36.9% from $166000.0 recorded in Q2 2025.
  • In the past 5 years, Bio's Other Working Capital Changes ranged from a high of $1.2 million in Q4 2021 and a low of -$497000.0 during Q1 2022
  • In the last 5 years, Bio's Other Working Capital Changes had a median value of -$254000.0 in 2023 and averaged -$34526.3.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first crashed by 18409.54% in 2022, then soared by 31698.11% in 2023.
  • Bio's Other Working Capital Changes (Quarter) stood at $1.2 million in 2021, then plummeted by 90.96% to $106000.0 in 2022, then soared by 316.98% to $442000.0 in 2023, then plummeted by 32.81% to $297000.0 in 2024, then plummeted by 191.58% to -$272000.0 in 2025.
  • Its last three reported values are -$272000.0 in Q3 2025, $166000.0 for Q2 2025, and -$180000.0 during Q1 2025.